EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieOpen Access · CC BY 4.0

Comparative Effectiveness of Calcium‐Channel Blockers, Angiotensin‐Converting Enzyme/Angiotensin Receptor Blockers and Diuretics on Cardiovascular Events Likelihood in Hypertensive African‐American and Non‐Hispanic Caucasians: A Retrospective Study Across HCA Healthcare

Anil Harrison, Sushil Rayamajhi, Farhad Shaker, Schwartz Thais, Melissa Moreno, Kaveh Hosseini iD

Clinical Cardiology · 2025

DOI: 10.1002/clc.70075 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Cardiology, 2025. Verfasst von Anil Harrison und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Midwestern University, Glendale, Arizona, USA. Hauptthemen laut MEDLINE: Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Calcium Channel Blockers, Cardiovascular Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension, a leading global risk factor for mortality and disability, disproportionately affects racial and ethnic minorities. Our study investigates the association between the type of prior antihypertensive medication use and the likelihood of cardiovascular events (CVE) and assesses whether the patient's race influences this relationship.

Methods

A retrospective study of 14 836 hypertension cases aged ≥ 40 years was conducted using data from HCA Healthcare between 2017 and 2023. Logistic regression was employed to predict the likelihood of CVE and mortality at admission, adjusting for baseline comorbidities, with Race added as an effect modifier. Interaction analysis was performed among races based on antihypertensive medication types.

Results

African American patients on ACE inhibitors (ACE) or angiotensin receptor blockers (ARBs) were 1.7 times more likely to have cardiovascular events (CVE) compared to those on calcium channel blockers (CCBs) and 0.66 times as likely compared to diuretics. CCB users had a lower CVE risk than diuretic users. Among White patients, ACE/ARB users had a 1.18 times higher CVE risk than CCB users and 0.45 times lower compared to diuretics, while CCBs offered a 0.38 times lower risk than diuretics. Only ACE/ARB use showed significantly higher CVE odds for African Americans compared to White patients, with similar risks across racial groups for CCBs and diuretics.

Conclusion

Prior antihypertensive type significantly influenced CVE risk, with race as an effect modifier. CCB users had lower CVE odds than ACE/ARBs or diuretics, and ACE/ARBs showed reduced CVE likelihood compared to diuretics in both racial groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersCardiovascular DiseasesDiureticsHypertensionAdultAgedFemaleHumansMaleMiddle AgedAntihypertensive AgentsBlack or African AmericanFollow-Up StudiesRetrospective StudiesRisk FactorsTreatment OutcomeUnited StatesWhite

Stichwörter der Autor:innen

African Americanantihypertensive agentscardiovascular eventshypertensionnon‐Hispanic Caucasians

Substanzen

Angiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsCalcium Channel BlockersDiuretics

Autor:innen und Institutionen

  • Department of Medicine, Midwestern University, Glendale, Arizona, USA.
  • Department of Internal Medicine, University of Central Florida College of Medicine/HCA Florida West Hospital, Pensacola, Florida, USA.
  • Tehran Heart Center, Cardiovascular Disease Research Institute, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
  • Department of Research and Statistics, HCA Healthcare Research, Nashville, Tennessee, USA.
  • Department of Mathematics and Systems Engineering, Florida Institute of Technology, Melbourne, Florida, USA.

ORCID-Profile: Kaveh Hosseini

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Harrison, A., Rayamajhi, S., Shaker, F., Thais, S., Moreno, M., & Hosseini, K. (2025). Comparative Effectiveness of Calcium‐Channel Blockers, Angiotensin‐Converting Enzyme/Angiotensin Receptor Blockers and Diuretics on Cardiovascular Events Likelihood in Hypertensive African‐American and Non‐Hispanic Caucasians: A Retrospective Study Across HCA Healthcare. Clinical Cardiology. https://doi.org/10.1002/clc.70075

Vancouver

Harrison A, Rayamajhi S, Shaker F, Thais S, Moreno M, Hosseini K. Comparative Effectiveness of Calcium‐Channel Blockers, Angiotensin‐Converting Enzyme/Angiotensin Receptor Blockers and Diuretics on Cardiovascular Events Likelihood in Hypertensive African‐American and Non‐Hispanic Caucasians: A Retrospective Study Across HCA Healthcare. Clinical Cardiology. 2025. doi:10.1002/clc.70075

BibTeX
@article{Harrison2025,
  author = {Harrison, Anil and Rayamajhi, Sushil and Shaker, Farhad and Thais, Schwartz and Moreno, Melissa and Hosseini, Kaveh},
  title = {Comparative Effectiveness of Calcium‐Channel Blockers, Angiotensin‐Converting Enzyme/Angiotensin Receptor Blockers and Diuretics on Cardiovascular Events Likelihood in Hypertensive African‐American and Non‐Hispanic Caucasians: A Retrospective Study Across HCA Healthcare},
  journal = {Clinical Cardiology},
  year = {2025},
  doi = {10.1002/clc.70075}
}
Kostenlos starten →